IP Library Granted Patent US 40,624
Granted Patent E1
US 40,624 · App. 11/900,008 · Granted Jan 20, 2009

Compositions and methods of using apoptosis signaling kinase related kinase (ASKRK)

Assignee: Metabolex, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 40,624
App. No.
11/900,008
Granted
Jan 20, 2009
Kind
E1
Abstract

The invention provides apoptosis signaling kinase related kinase (ASKRK) nucleic acid and polypeptide sequences and methods of using such sequences to identify modulators of ASKRK. Such modulators can be used for the treatment of diabetes or for delaying the onset of diabetes. The invention also provides methods of diagnosing diabetes or pre-diabetes and methods of making a prognosis based on the detection of ASKRK nucleic acids and proteins.

Claims (5)

1. An isolated nucleic acid encoding a polypeptide comprising SEQ ID NO:2.

2. The isolated nucleic acid of claim 1 , wherein the nucleic acid comprises SEQ ID NO:1.

3. An expression vector comprising the nucleic acid of claim 1 .

4. A host cell in vitro comprising the expression vector of claim 3 .

5. The host cell of claim 4 , wherein the host cell is a pancreatic beta cell.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Aug 7, 2015
From: SILICON VALLEY BANK; OXFORD FINANCE LLC
To: CYMABAY THERAPEUTICS, INC.
Reel/Frame 036307/0406 →
SECURITY AGREEMENT Recorded Nov 22, 2013
From: CYMABAY THERAPEUTICS, INC.
To: SILICON VALLEY BANK; OXFORD FINANCE LLC
Reel/Frame 031710/0508 →
CHANGE OF NAME Recorded Oct 30, 2013
From: METABOLEX, INC.
To: CYMABAY THERAPEUTICS, INC.
Reel/Frame 031516/0909 →
Continuity (2)
Reissue 1098097400 · Nov 3, 2004
Provisional Application 6051747700 · Nov 4, 2003